PodcastsWetenschapThe Long Run with Luke Timmerman

The Long Run with Luke Timmerman

Timmerman Report
The Long Run with Luke Timmerman
Nieuwste aflevering

191 afleveringen

  • The Long Run with Luke Timmerman

    Ep193: Ron Renaud on Helping People Lose Weight With GLP-1 Medicines

    22-1-2026 | 1 u. 5 Min.
    Ron Renaud, CEO of Waltham, Mass.-based Kailera Therapeutics, on developing GLP-1 based medicines to help people lose weight and live healthier lives.
  • The Long Run with Luke Timmerman

    Ep192: Kate Haviland on Following the Science to Precision Immunology

    08-1-2026 | 1 u. 26 Min.
    Kate Haviland, former CEO of Blueprint Medicines, on how the company transitioned to a precision immunology company and was acquired by Sanofi for $9.5 billion.
  • The Long Run with Luke Timmerman

    Ep191: Emily Conley on Small Molecules to Correct a Rare Kidney Disease

    15-12-2025 | 1 u. 7 Min.
    Emily Conley, CEO of Berkeley, CA-based Renasant Bio, on developing small molecule correctors and potentiators for autosomal dominant polycystic kidney disease (ADPKD).
  • The Long Run with Luke Timmerman

    Ep190: Neil Kumar on Building a Rare Disease Drug Company

    20-11-2025 | 1 u. 13 Min.
    Neil Kumar is founder and CEO of Palo Alto, Calif.-based BridgeBio Pharma, a rare disease drug developer.
  • The Long Run with Luke Timmerman

    Ep189: Marc Tessier-Lavigne on Reinventing Drug Discovery with AI

    12-11-2025 | 1 u. 12 Min.
    Marc Tessier-Lavigne, CEO of South San Francisco-based Xaira Therapeutics, on reinventing drug discovery with AI.

Meer Wetenschap podcasts

Over The Long Run with Luke Timmerman

"The Long Run" Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.
Podcast website

Luister naar The Long Run with Luke Timmerman, Vroege Vogels en vele andere podcasts van over de hele wereld met de radio.net-app

Ontvang de gratis radio.net app

  • Zenders en podcasts om te bookmarken
  • Streamen via Wi-Fi of Bluetooth
  • Ondersteunt Carplay & Android Auto
  • Veel andere app-functies